| Global mortality associated with 33 bacterial pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019 KS Ikuta, LR Swetschinski, GR Aguilar, F Sharara, T Mestrovic, AP Gray, ... The Lancet 400 (10369), 2221-2248, 2022 | 538 | 2022 |
| Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 KL Ong, LK Stafford, SA McLaughlin, EJ Boyko, SE Vollset, AE Smith, ... The Lancet 402 (10397), 203-234, 2023 | 467 | 2023 |
| The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ... The Lancet 400 (10352), 563-591, 2022 | 392 | 2022 |
| Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026 AE Micah, K Bhangdia, IE Cogswell, D Lasher, B Lidral-Porter, ... The Lancet Global Health 11 (3), e385-e413, 2023 | 120 | 2023 |
| Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 HH Kyu, A Vongpradith, SB Sirota, A Novotney, CE Troeger, MC Doxey, ... The Lancet infectious diseases 22 (11), 1626-1647, 2022 | 100 | 2022 |
| Global burden of chronic respiratory diseases and risk factors, 1990–2019: an update from the Global Burden of Disease Study 2019 S Momtazmanesh, SS Moghaddam, SH Ghamari, EM Rad, N Rezaei, ... EClinicalMedicine 59, 2023 | 84 | 2023 |
| Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000–2021: a systematic analysis from the Global Burden of Disease Study 2021 AM Thomson, TA McHugh, AP Oron, C Teply, N Lonberg, VV Tella, ... The Lancet Haematology 10 (8), e585-e599, 2023 | 81 | 2023 |
| A global, regional, and national survey on burden and Quality of Care Index (QCI) of hematologic malignancies; global burden of disease systematic analysis 1990–2017 M Keykhaei, M Masinaei, E Mohammadi, S Azadnajafabad, N Rezaei, ... Experimental hematology & oncology 10, 1-15, 2021 | 75 | 2021 |
| A global, regional, and national survey on burden and Quality of Care Index (QCI) of brain and other central nervous system cancers; global burden of disease systematic … E Mohammadi, E Ghasemi, S Azadnajafabad, N Rezaei, ... PloS one 16 (2), e0247120, 2021 | 63 | 2021 |
| The prevalence, awareness, and treatment of lipid abnormalities in Iranian adults: Surveillance of risk factors of noncommunicable diseases in Iran 2016 Z Aryan, N Mahmoudi, A Sheidaei, S Rezaei, Z Mahmoudi, K Gohari, ... Journal of clinical lipidology 12 (6), 1471-1481. e4, 2018 | 55 | 2018 |
| A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions O Tabatabaei-Malazy, S Saeedi Moghaddam, N Rezaei, A Sheidaei, ... PloS one 16 (3), e0241926, 2021 | 50 | 2021 |
| Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990–2021: findings from the Global Burden of Disease Study 2021 GBDA Collaborators The Lancet Haematology 10 (9), e713-e734, 2023 | 48 | 2023 |
| Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global … YH Shin, J Hwang, R Kwon, SW Lee, MS Kim, ... Allergy 78 (8), 2232-2254, 2023 | 42 | 2023 |
| Enhancing global vaccine pharmacovigilance: proof-of-concept study on aseptic meningitis and immune thrombocytopenic purpura following measles-mumps containing vaccination S Perez-Vilar, D Weibel, M Sturkenboom, S Black, C Maure, JL Castro, ... Vaccine 36 (3), 347-354, 2018 | 37 | 2018 |
| Adolescent transport and unintentional injuries: a systematic analysis using the Global Burden of Disease Study 2019 AE Peden, P Cullen, KL Francis, H Moeller, MM Peden, P Ye, M Tian, ... The Lancet Public Health 7 (8), e657-e669, 2022 | 34 | 2022 |
| Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: A phase I/II randomized placebo-controlled clinical trial M Izadi, A Sadr Hashemi Nejad, M Moazenchi, S Masoumi, A Rabbani, ... Stem Cell Research & Therapy 13 (1), 264, 2022 | 31 | 2022 |
| Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021 RJ Black, M Cross, LM Haile, GT Culbreth, JD Steinmetz, H Hagins, ... The Lancet Rheumatology 5 (10), e594-e610, 2023 | 28 | 2023 |
| Trends of national and subnational incidence of childhood cancer groups in Iran: 1990–2016 M Shabani, S Saeedi Moghaddam, B Ataeinia, N Rezaei, F Mohebi, ... Frontiers in Oncology 9, 1428, 2020 | 28 | 2020 |
| Quality evaluation of national cancer registry system in Iran: study protocol M Modirian, S Rahimzadeh, Z Cheraghi, A Khosravi, H Salimzadeh, ... ARCHIVES OF IRANIAN MEDICINE 17 (3), 193-197, 2014 | 27 | 2014 |
| Global, regional, and national survey on the burden and quality of care of pancreatic cancer: a systematic analysis for the Global Burden of Disease study 1990–2017 A Aryannejad, M Tabary, N Ebrahimi, E Mohammadi, N Fattahi, ... Pancreatology 21 (8), 1443-1450, 2021 | 24 | 2021 |
